Clinical Scorecard: Evaluation of Initial Findings from Psilocybin-Enhanced Psychotherapy for Cocaine Use Disorder
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Care Setting
Clinical settings with trained therapists, though lacking standardized workforce training; specify the implications of this gap.
Key Highlights
Pilot study showed potential for psilocybin-assisted therapy to improve cocaine-related outcomes over 180 days, but secondary outcomes were not reported.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Regular toxicology screenings and clinical visits for patients undergoing CM, ideally bi-weekly for the first three months.
Risks
Patient & Prescribing Data
Adults with Cocaine Use Disorder, excluding those on antidepressants or with current psychiatric disorders.
Psilocybin-assisted therapy involves multiple sessions and requires significant therapist training and resources.
Clinical Best Practices
Implement fidelity monitoring in psychotherapy to ensure standardized treatment delivery.
Utilize contingency management as a practical and effective treatment option.
Engage diverse populations in treatment trials to enhance generalizability of results.
Address training needs for therapists involved in psilocybin-assisted therapy.
